TCG Crossover GP II, LLC - 10 Oct 2025 SCHEDULE 13G Report for Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
Chen Yu
Security
Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
GLUE
Shares outstanding
61,495,903 shares
Disclosed Ownership
4,427,705 shares
Ownership
7.2%
Form type
SCHEDULE 13G
Filing time
17 Oct 2025, 16:29:25 UTC
Date of event
10 Oct 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 3.6% 2,213,853 0 2,213,853 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 3.6% 2,213,853 0 2,213,853 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover GP III, LLC 3.6% 2,213,852 0 2,213,852 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund III, L.P. 3.6% 2,213,852 0 2,213,852 /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 7.2% 4,427,705 0 4,427,705 /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu